BNTX - CIK 0001776985
BioNTech SE trades as BNTX and has a market capitalization of $21.79 B, making it the #587 largest US-listed company by market value. This page tracks BioNTech SE through 548 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-22 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| 6-K | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
Revenues for the first quarter of 2026 were €118.1 million, compared to €182.8 million for the comparative prior year period. The decrease was ...
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 ... MAINZ, Germany, April 21, 2026 (GLOBE NEWSWIRE) -- BioNTech SE ( ...
The largest companies sharing BioNTech SE's SEC industry classification (biological products, (no diagnostic substances)).
BioNTech SE (BNTX) has a market capitalization of $21.79 B as of 2026-06-10, ranking #587 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.